Amneal Pharmaceuticals, Inc.
AMRX
23 insider filings · Latest: May 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | Mar 5 10:02 PM | Alva Emily Peterson | Proposed Sale | 85,000 | $8.87 | $754.0K | — | View → |
| Mar 5, 2025 | Mar 5 10:00 PM | BOYER ANDREW S | Proposed Sale | 125,000 | $8.87 | $1.1M | — | View → |
| Mar 5, 2025 | Mar 5 9:57 PM | Daly Jason B. | Proposed Sale | 90,000 | $8.80 | $792.0K | — | View → |
| Mar 5, 2025 | Mar 5 3:00 PM | Konidaris Tasos | Proposed Sale | 100,000 | $8.84 | $884.0K | — | View → |
| Nov 22, 2024 | Nov 22 3:39 PM | Kiely John | Proposed Sale | 17,058 | $8.33 | $142.2K | — | View → |
| Nov 21, 2024 | Nov 21 7:01 PM | Autor Deborah M. | Proposed Sale | 50,000 | $8.38 | $419.0K | — | View → |
| Nov 15, 2024 | Nov 15 6:49 PM | Daly Jason B. | Proposed Sale | 57,322 | $8.50 | $487.2K | — | View → |
| Jan 2, 2025 | — | Gautam J Patel | Proposed Sale | 320,000 | $8.00 | $2.6M | — | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Mar 5 9:51 PM | Patel Chirag K.Director, President & Co-CEO | Option Exercise | 92,593 | — | 185,185(D) | View → |
| Mar 3, 2026 | Mar 5 9:51 PM | Patel Chirag K.Director, President & Co-CEO | Option Exercise | 793,875 | — | 0(D) | View → |
| Mar 4, 2026 | Mar 5 9:32 PM | Jason B. DalyEVP, Chief Legal Officer | Option Exercise | 35,880 | — | 71,760(D) | View → |
| Mar 3, 2026 | Mar 5 9:32 PM | Jason B. DalyEVP, Chief Legal Officer | Option Exercise | 390,939 | — | 0(D) | View → |
| Mar 4, 2026 | Mar 5 9:31 PM | Tasos KonidarisExecutive Vice President & CFO | Option Exercise | 49,982 | — | 87,963(D) | View → |
| Mar 3, 2026 | Mar 5 9:31 PM | Tasos KonidarisExecutive Vice President & CFO | Option Exercise | 589,883 | — | 0(D) | View → |
| Mar 4, 2026 | Mar 5 9:31 PM | Andrew S BoyerExecutive Vice President | Option Exercise | 38,195 | — | 76,389(D) | View → |
| Mar 3, 2026 | Mar 5 9:31 PM | Andrew S BoyerExecutive Vice President | Option Exercise | 510,758 | — | 0(D) | View → |
| Mar 4, 2026 | Mar 5 9:30 PM | Nikita ShahExecutive Vice President | Option Exercise | 35,880 | — | 71,760(D) | View → |
| Mar 3, 2026 | Mar 5 9:30 PM | Nikita ShahExecutive Vice President | Option Exercise | 472,619 | — | 0(D) | View → |
| Mar 2, 2026 | Mar 3 9:29 PM | Patel ChintuDirector, Co-CEO | Grant/Award | 544,663 | — | 354,031(D) | View → |
| Mar 2, 2026 | Mar 3 9:29 PM | Patel Chirag K.Director, President & Co-CEO | Grant/Award | 544,663 | — | 354,031(D) | View → |
| Mar 2, 2026 | Mar 3 9:28 PM | Nikita ShahExecutive Vice President | Grant/Award | 130,718 | — | 65,359(D) | View → |
| Mar 2, 2026 | Mar 3 9:28 PM | Tasos KonidarisExecutive Vice President & CFO | Grant/Award | 145,244 | — | 72,622(D) | View → |
| Mar 2, 2026 | Mar 3 9:27 PM | Jason B. DalyEVP, Chief Legal Officer | Grant/Award | 130,718 | — | 65,359(D) | View → |
| Mar 2, 2026 | Mar 3 9:26 PM | Andrew S BoyerExecutive Vice President | Grant/Award | 130,718 | — | 65,359(D) | View → |
← Previous
Page 2 of 2